Author:
Chao Y.,Chen J. S.,Hunt V. M.,Kuron G. W.,Karkas J. D.,Liou R.,Alberts A. W.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference11 articles.
1. Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in incidence of coronary heart disease; II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251:351?374
2. Turley SD, Dietschy JM (1982) Arias I, Popper H, Schachter D, Shafritz DA (eds) In: The liver: biology and pathobiology. Raven Press, New York, pp 467?492
3. Tsuijita Y, Kuroda M, Shimada Y, Tanzawa K, Arai M, Kaneko I, Tanaka M, Masuda H, Tarumi C, Watanabe Y (1986) CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim Biophys Acta 887:50?60
4. Saito Y, Shiki Y, Shirai K, Yoshida S (1988) Effect of a new synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on cholesterol synthesis and low density lipoprotein uptake by primary cultures of rat hepatocytes. ArzneimittelForsch/Drug Res 38:251?253
5. Germershausen JI, Hunt VM, Bostedor RG, Bailey PJ, Karkas JD, Alberts AW (1989) Tissue selectivity of the cholesterol lowering agents lovastatin, simvastatin and pravastatin in rats in vivo. Biochem Biophys Res Commun 158:667?675
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献